We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,067 results
  1. Atypical extrapyramidal manifestation of a typical antipsychotic with serotonergic antidepressant

    Introduction

    Typical antipsychotics are known to produce extrapyramidal side effects such as drug induced parkinsonism, acute dystonia, akathisia,...

    Rohit Singh, Sankha Shubhra Chakrabarti, Upinder Kaur in DARU Journal of Pharmaceutical Sciences
    Article 14 November 2023
  2. POLR3A variants with striatal involvement and extrapyramidal movement disorder

    Biallelic variants in POLR3A cause 4H leukodystrophy, characterized by hypomyelination in combination with cerebellar and pyramidal signs and...

    Inga Harting, Murtadha Al-Saady, ... Nicole I. Wolf in neurogenetics
    Article Open access 15 January 2020
  3. Reporting a rare form of myopathy, myopathy with extrapyramidal signs, in an Iranian family using next generation sequencing: a case report

    Background

    Myopathy with extrapyramidal signs (MPXPS) is an autosomal recessive mitochondrial disorder which is caused by mutation in mitochondrial...

    Marzieh Mojbafan, Somayeh Takrim Nojehdeh, ... Sirous Zeinali in BMC Medical Genetics
    Article Open access 15 April 2020
  4. Correlation Between the SARA and A-T NEST Clinical Severity Scores in Adults with Ataxia-Telangiectasia

    Ataxia-Telangiectasia (A-T) is an autosomal recessive neurodegenerative disease associated with cerebellar ataxia and extrapyramidal features. A-T...

    Toby Major, May Yung Tiet, ... Anke E. Hensiek in The Cerebellum
    Article Open access 10 April 2023
  5. Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study

    Objective

    Despite advances in pharmacology, the treatment of schizophrenia (SZ) remains a challenge due to relapse after antipsychotic discontinuation...

    **aoe Lang, Mei Xue, ... **angyang Zhang in Journal of Translational Medicine
    Article Open access 04 July 2023
  6. Autoimmune parkinsonism with faciobrachiocrural dystonic seizures: a new phenotype of leucine-rich glioma-inactivated 1 (LGI1) autoimmunity

    Extrapyramidal symptoms are seen in patients with leucine-rich glioma-inactivated 1 ( LGI1 ) antibody-positive patients infrequently and this can be...

    Sruthi Sasikumar, **o Vincent, ... Anandkumar Anandakuttan in Acta Neurologica Belgica
    Article 18 July 2022
  7. Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms

    Introduction

    We explore the transcription factors involved in the molecular mechanism of antipsychotic (AP)-induced acute extrapyramidalsymptoms (EPS)...

    Daniel Boloc, Natalia Rodríguez, ... Joan Albert Arnaiz in Psychopharmacology
    Article 07 May 2020
  8. Managing Schizophrenia: A Challenge for Physicians

    Schizophrenia is a dreaded mental disorder that causes the affected person to believe in distorted perceptions of reality and affects their quality...
    Chapter 2023
  9. Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease

    Background

    Rapidly progressive forms of Alzheimer’s disease (rpAD) are increasingly recognized and may have a prevalence of up to 30% of patients...

    Janne Marieke Herden, Peter Hermann, ... Inga Zerr in Alzheimer's Research & Therapy
    Article Open access 08 June 2023
  10. Histomorphological evaluations on the frontal cortex extrapyramidal cell layer following administration of N-Acetyl cysteine in aluminum induced neurodegeneration rat model

    Aluminum is a potent neurotoxin used in animal models of neurodegenerative diseases like Alzheimer’s disease (AD), in which oxidative stress mediates...

    Memudu Adejoke Elizabeth, Pantong Samson, Osahon Roli Itohan in Metabolic Brain Disease
    Article Open access 24 March 2020
  11. Spastic Paraplegia Type 7 (SPG7)

    Hereditary Spastic Paraplegia (HSP) is a genetically heterogeneous disorders associated with different modes of inheritance and multiple loci and...
    Gorka Fernández-Eulate, Aurora Pujol, Adolfo López de Munain in Essentials of Cerebellum and Cerebellar Disorders
    Chapter 2023
  12. L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial

    Rationale

    Inadequate responses to current schizophrenia treatments have accelerated research into novel therapeutic approaches.

    Objectives ...
    Ahmad Shamabadi, Setareh Fattollahzadeh-Noor, ... Shahin Akhondzadeh in Psychopharmacology
    Article 12 September 2023
  13. Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial

    Rationale

    The efficacy and safety of antidepressant augmentation therapy with aripiprazole (AATA) has been established; however, the ongoing effects...

    Masahiro Takeshima, Akise Umakoshi, ... Kazuo Mishima in Psychopharmacology
    Article Open access 28 March 2024
  14. Long-term neurologic outcomes of COVID-19

    The neurologic manifestations of acute COVID-19 are well characterized, but a comprehensive evaluation of postacute neurologic sequelae at 1 year has...

    Evan Xu, Yan **e, Ziyad Al-Aly in Nature Medicine
    Article Open access 22 September 2022
  15. Differences in the incidence of lurasidone adverse events between depressive disorders and schizophrenia in double-blind, randomized, placebo-controlled trials: a meta-analysis

    Rationale

    We conducted a meta-analysis of double-blind, randomized placebo-controlled trials of lurasidone (LUR) to examine the difference in the risk...

    Taro Kishi, Hiroshi Nakamura, Nakao Iwata in Psychopharmacology
    Article 02 September 2021
  16. Clinical and neuroradiological notes on non-extrapyramidal bent spine syndrome

    Giuliana Galassi, Maurilio Genovese, ... Gianni De Berti in Acta Neurologica Belgica
    Article 30 October 2019
  17. Cerebellar cognitive-affective syndrome preceding ataxia associated with complex extrapyramidal features in a Turkish SCA48 family

    SCA48 is a novel spinocerebellar ataxia (SCA) originally and recently characterized by prominent cerebellar cognitive-affective syndrome (CCAS) and...

    R. Palvadeau, Z. E. Kaya-Güleç, ... S. Ertan in neurogenetics
    Article 19 November 2019
  18. Ion Channel Genes and Ataxia

    In this review we will discuss ataxic disorders attributed to mutations in ion channel genes. Such disorders seem to preferentially effect cerebellar...
    Mahesh Padmanaban, Christopher M. Gomez in Trials for Cerebellar Ataxias
    Chapter 2023
  19. Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life

    Age and HIV disease have additive effects on neural systems that support motor functioning. The current study examined the combined impact of aging...

    Savanna M. Tierney, Steven Paul Woods, ... Ronald J. Ellis in Journal of NeuroVirology
    Article 10 December 2018
  20. Risk of renal impairment in atypical antipsychotics: a systematic review and meta-analysis

    Purpose

    Atypical antipsychotics are associated with several adverse effects including metabolic syndrome, weight gain, QTc interval prolongation, and...

    Leong Tung Ong, Nicholas Ming Zher Chee, Audrey Joe Chii Loh in European Journal of Clinical Pharmacology
    Article 25 June 2024
Did you find what you were looking for? Share feedback.